Sareum Holdings (FRA:RYH0) Tariff Resilience Score: 0/10 (As of Jul. 11, 2026)


FRA:RYH0 Sareum Holdings PLC FRA:RYH0
36 GF Score
Price €0.22
! 3 Warning Signs
View Full Analysis

What is Sareum Holdings Tariff Resilience Score?

Sareum Holdings has the Tariff Resilience Score of 0, which implies that the company might have .

Sareum Holdings has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Sareum Holdings might have .


Sareum Holdings  (FRA:RYH0) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Sareum Holdings Tariff Resilience Score Related Terms

FRA:RYH0
36GF Score
Sareum Holdings PLC FRA:RYH0
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sareum Holdings Business Description

Other Exchanges SAR:UK
Address Langford Arch, London Road, Unit 2a, Pampisford, Cambridge, Cambridgeshire, GBR, CB22 3FX
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.
36GF Score

Get the complete analysis for FRA:RYH0

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.22
Price